TAT Technologies reported record third-quarter revenue of $55.6 million, a 20.2% increase from the previous year, driven by strong demand and operational efficiency. Adjusted EBITDA surged 60.9% to $10.9 million, with a margin of 19.6%, while diluted earnings per share rose 57.8% to $0.58. The company benefits from strong customer relationships and a $577 million backlog, positioning it for continued growth. Despite increased inventory investment impacting cash flow, TAT is optimistic about future opportunities, especially with its expanded agreement with Honeywell.
TAT Technologies' record third-quarter results provide context for readers following industrial companies. For readers following Industrials, here is Pluang's market snapshot as of Nov 02, 2026 18:11 WIB: Among 135 priced US Industrials stocks, 80 rose and 24 fell today. Vertiv Holdings Co (VRT) gained 2.68% to USD 238.74 with a typical hold time of 45 days, Eos Energy Enterprises Inc (EOSE) rose 2.65% to USD 1.94 held typically for 18 days, and Planet Labs (PL) increased 2.52% to USD 13.81 with a typical hold time of 10 days.
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
